Chapter 10 - General Advice on Vigilance - Northern Ireland

AI Summary

This guidance document outlines the regulatory obligations for manufacturers and importers of electronic cigarettes and refill containers operating in Northern Ireland. Under the regulatory framework of Article 20 of Directive 2014/40/EU, as implemented by the Tobacco and Related Products Regulations 2016 (TRPR) and the 2020 EU Exit Regulations, producers must notify the Medicines and Healthcare products Regulatory Agency (MHRA) before marketing their products. A central requirement is the establishment of a robust vigilance system to monitor and record suspected adverse health effects, customer complaints, and internal quality testing results. Key compliance issues identified include the necessity for producers to maintain an address within an EU member state for information collection and to include these contact details on all product packaging or leaflets. If a product is found to be unsafe or non-compliant with quality standards, producers are required to take immediate corrective action, which may include withdrawing or recalling the product. Companies must promptly inform the MHRA of such risks and the resulting actions taken via the designated safety email. Furthermore, the MHRA mandates that producers develop and test quarantine and recall procedures to ensure public safety. The MHRA actively monitors product safety through its Yellow Card Scheme and may require additional information or further remedial actions from companies to minimize public health risks.